Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2007, Pages

  Mochtar, Monique H ^a   Van Der Veen, F ^b   Ziech, M ^b   Van Wely, M ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Drug therapy, combination; Fertilization in vitro methods ; Follicle stimulating hormone administration dosage ; Luteinizing hormone *administration dosage ; Ovulation induction *methods ; Randomized controlled trials as topic

Indexed keywords

ESTRADIOL; GONADORELIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN; LEUPRORELIN; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE;

BIRTH RATE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG SAFETY; EMBRYO TRANSFER; FERTILIZATION IN VITRO; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; INFERTILITY; INTRACYTOPLASMIC SPERM INJECTION; MONOTHERAPY; OVARY HYPERSTIMULATION; PREGNANCY RATE; REVIEW;

EID: 37549017689     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005070.pub2     Document Type: Review

References (41)

1. Abdelmassih 2006 {published data only} Abdelmassih V, Salgueiro R, Abdelmassih C, Carizza C. Less miscarriage rate using LH (rLH) in GnRH agonists long protocols. Abstracts of the 22nd Annual Meeting of the Eshre, O-017, i7. 2006.
2. Balasch 2001 {published data only} Balasch J, Creus M, Fabregues F, Civico S, Carmona F, Puerto B, et al.The effect of exogeneous luteinizing hormone (LH) on oocyte viability: Evidence from a comparative study using recombinant human follicle-stimulating hormone (FSH) alone or in combination with recombinant LH for ovarian hyperstimulation in pituitary-suppressed women undergoing assisted reproduction. Journal of Assisted Reproductive Genetics 2001;18(5):250-6.
3. Barrenetxea 2006 {published data only} Barrenetxea G, Agirregoika JA, Lopez de Larruzea A, Ganzabal T, Jimenez MR, Carbonero K, et al.LH supplementation in ovarian stimulation in poor responder women. A randomized controlled trial. Abstracts of the 22 Annual Meeting of the ESHRE, i55. 2006.
4. De Placido 2005 {published data only} De Placido G, Alviggi C, Perino A, Strina I, Lisi F, Fasolino A, et al.Recombinant human LH supplementation versus recombinant human FSH(rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial in adequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Human Reproduction 2005;20(2):390-6.
5. Ferraretti 2004 {published and unpublished data} Ferraretti AP, Gianaroli L, Magli MC, D'Angelo A, Farfalli V, Montanaro N. Exogeneous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproductive techniques. Fertility and Sterility 2004;82(6):1521- 6.
6. Fábreques 2006 {published data only} Fabregues F, Creus M, Penarrubia J, Manau D, Vanrell JA, Balasch J. Effects of recombinant human luteinizing hormone supplementation on ovarian stimulation and the implantation rate in down-regulated women of advanced reproductive age. Fertility and Sterility 2006;85:925-31.
7. Griesinger 2005 {published data only} Griesinger G, Schultze-Mosgau A, Dafopoulos K, Schroeder A, Schroer A, von Otte S, et al.Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol. Human Reproduction 2005;20(5):1200-6.
8. Humaidan 2004 {published data only} Humaidan. Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study. Reproductive Biomedine 2004;8:635-43.
9. Levi-Setti 2006 {published data only} Levi-Setti PE, Cavagna M, Bulletti C. Recombinant gonadotrophins associated with GnRH antagonist (cetrorelix) in ovarian stimulation for ICSI: comparison of rFSH alone and in combination with rLH. European Journal ofObstetrics and Gynecology and Reproductive Biology 2006;126:212-16.
10. Lisi 2005 {published data only} Lisi F, Rinaldi L, Fishel S, Caserta D, Lisi R, Campbell A. Evaluation of two doses of recombinant luteinizing hormone supplementation in an unselected group of women undergoing follicular stimulation for in vitro fertilization. Fertil Steril, 83 (2) 309-315 2005;83(2):309-315.
11. Marrs 2003 {published data only} *Marrs R, Meldrum D, Muasher S, Schoolcraft W, Werlin L, Kelly E. Randomized trial to compare the effect of recombinant FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction trreatment. Reprod BioMed Online/Article/986 2003;8(2):175-182.
12. Nyboe Andersen 2006 {published data only} Nyboe Andersen A, Humaidan P, Fried G. Addition of rLH (Luveris) to rFSH during the final days of folliculair maturation in IVF/ICSI treated patients. A Nordic randomized multicentred trial. Abstracts if the 22nd Annula Meeting of the ESHRE, O-138,i54, 2006. 2006.
13. Sauer 2004 {published data only} Sauer MV, Thornton MH 2nd, Schoolcraft W, Frishman GN. Comparative efficacy and safety of cetrorelix with or without mid-cycle recombinant LH and leuprolide acetate for inhibition of premature LH surges in assisted reproduction. Reproductive Biomedicine Online 2004;9(5):487-93.
14. Tarlatzis 2006 {published data only} Tarlatzis B, Tavmergen E, Szamatowicz M, Barash A, Amit A, Levitas E, et al.The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: a double-blind, randomized, prospective study. Human Reproduction 2006;21(1):90-4.
15. Acévedo 2004 Acevedo B, Sanchez M, Gomez JL, Cuadros J, Ricciarelli E, Hernandez ER. Luteinizing hormone supplementation increases pregnancy rates in gonadotropin-releasing hormone antagonist donor cycles. Fertility and Sterility 2004;82(2):343.
16. Cedrin-Durnerin 2004 Cedrin-Durnerin I, Grange-Dujardin D, Laffy A, Parneix I, Massin N, Galey J, et al.Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study. Hum Reprod. 2004 Sep;19(9):1979-84. Epub 2004 Jun 10 2004;19(9):1979-1984.
17. De Placido 2004 De Placido G, Alviggi C, Mollo A, Strina I, Ranieri A, Alviggi E, et al.Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an intial inadequate response to recombinant FSH (rFSH) after pituitary downregulation. Clin Endocrin, 60, 637-643 2004;60:637-643.
18. Drakakis 2005 Drakakis P, Loutradis D, Kallianidis K, Liapi A, Milingos S, Makrigiannakis A, et al.Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET. European Journal Obstetrics Gynecology and Reproductive Biology 2005;121(1):77-80.
19. Hugues 2005 Hugues JN, Soussis J, Calderon I, Balasch J, Anderson RA, Romeu A, Recombinant LH Study Group. Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding study. Human Reproduction 2005;20(3):629-35.
20. Lisi 2001 Lisi F, Rinaldi L, Fishel S, Lisi R, Pepe G, Picconeri MG, et al. Use of recombinant FSH and recombinant LH in multiple follicular stimulation for IVF: a preliminary study. Use of recombinant FSH and recombinant LH in multiple follicular stimulation for IVF: a preliminary study. Reproductive Biomedicine Online 2001;3(3):190-94.
21. Lisi 2002 Lisi F, Rinaldi L, Fishel S, Lisi R, Pepe GP, Picconeri MG, et al. Use of recombinant LH in a group of unselected IVF patients. Reprroductive Medicine Online 2002;5(2):104-8.
22. Lisi 2003 Lisi F, Rinaldi L, Fishel S, Lisi R, Pepe G, Picconeri MG. Use of recombinant follicle-stimulating hormone (Gonal F) and recombinant luteinizing hormone (Luveris) for multiple follicular stimulation in patients with a suboptimal response to in vitro fertilization. Use of recombinant follicle-stimulating hormone (Gonal F) and recombinant luteinizing hormone (Luveris) for multiple follicular stimulation in patients with a suboptimal response to in vitro fertilization. Fertility and Sterility 2003;79(4):1037-8.
23. Motta 2006 Motta E.L.A, Maia V, Massaguer A, Fassolas G, Rocca T, Rossi LM, et al.Administration of either recombinant LH or increasing dose of recombinant FSH in late follicular phase of patients with suboptimal response. Abstracts of the 22nd Annual Meeting of ESHRE, O-141, i55. 2006.
24. Sills 1999 Sills ES, Levy DP, Moomjy M, McGee M, Rosenwaks Z. A prospective, randomized comparison of ovulation induction using highly purified follicle-stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilization. Human Reproduction 1999;14(9):2230-5.
25. Tesarik 2002 Tesarik J, Mendoza C. Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence. Human Reproduction 2002;17(12):3129-37.
26. Broekmans 1992 Broekmans F, Bernardus R, Berkhout G, Schoenmaker J. Pituitary and ovarian suppression after early follicular and mid-luteal administration of LHRH agonist in a depot formulation: decapeptyl CR. Gynecoligal Endocrinology 1992;6:153-61.
27. Chappel 1991 Chappel SC, Howles C. Reevaluation of the roles of luteinizing hormone and follicle stimulation hormone in the ovulatory process. Human Reproduction 1991;6:1206-12.
28. Daya 2002 Daya S. Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction. Fertility and Sterility 2002;77(4):711-4.
29. Ganirelix Study 1998 Ganirelix Dose-Finding Study Group. A double-blind randomized, dose-finding study to assess the efficacy of the gonadotropin-releasing hormone antagonist ganirelix to prevent premature LH surges in women undergoing ovarian stimulation with recombinant FSH. Human Reproduction 1998;13:3023-31.
30. Higgins 2003 Higgins JP, Tompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557- 60.
31. Hugues 1998 Hugues J-N, Durnerin IC. Revisiting gonadotropin-releasing hormone agonist and management of poor ovarian responses to gonadotropins. Human Reproduction Update 1998;4:83-101.
32. Hull 1994 Hull M, Corrigan E, Piazzi A, Loumaye E. Recombinant human luteinizing hormone: an effective new gonodotropin preparation. Lancet 1994;344(8918):334-5.
33. Levy 2000 Levy DP, Navarro JM, Schattman G, Davis OK, Rosenwaks Z. The role of LH in ovarian stimulation. Human Reproduction 2000;15:2258-65.
34. Out 1996 Out HJ, Mannaerts BM, Driessen SG, Coelingh Bennink HJ. Recombinant follicle stimulating hormone (rFSH; Puregon) in assisted reproduction: more oocytes, more pregnancies. Results from five comparative studies. Human Reproduction Update 1996;2(2):162-71.
35. Placido 2001 Placido G, Mollo A, Alviggi C, Strina I, Varricchio MT, Ranieri A, et al.Rescue of IVF cycles by HMG in pituitary down-regulated normogonadotropic young women characterized by a poor initial respons to recombinant FSH. Human Reproduction 2001;16:1875-9.
36. Porter 1984 Porter RN, Smith W, Craft IL, Abdulwahid NA, Jacobs HS. Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins. Lancet 1984;2(8414):1284-5.
37. Short 1962 Short RV. Steroids in the follicular fluid and the corpus luteum of the mare. A 'two-cell type' theory of ovarian steroid synthesis. Journal of Endocrinology 1962;24:59-63.
38. Smitz 1988 Smitz J. Devroey P, Camus M, et al.The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT. Human Reproduction 1988;5:585-90.
39. Vail 2003 Vail A, Gardener E. Common statistical errors in the design and analysis of subfertility trials. Human Reproduction 2003;18:1000-4.
40. van Wely 2002 Van Wely M, Westergaard LG, Bossuyt PMM, van der Veen F. Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles. The Cochrane Library 2002, Issue 2.Art. No.: CD003973. DOI:10.1002/14651858.CD003973.
41. Westergaard 2000 Westergaard LG, Laursen SB, Andersen CY. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotropic women undergoing assisted reproduction. Human Reproduction 2000;15:1003-8.